Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/33529
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorLIN, Lawrence Hsu
dc.contributor.authorPOLIZIO, Rodrigo
dc.contributor.authorFUSHIDA, Koji
dc.contributor.authorFRANCISCO, Rossana Pulcineli Vieira
dc.date.accessioned2019-09-23T14:19:22Z-
dc.date.available2019-09-23T14:19:22Z-
dc.date.issued2019
dc.identifier.citationSEMINARS IN ULTRASOUND CT AND MRI, v.40, n.4, p.332-349, 2019
dc.identifier.issn0887-2171
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/33529-
dc.description.abstractGestational trophoblastic disease (GTD) is a spectrum of disorders characterized by abnormal trophoblastic proliferation. GTD includes benign conditions such as hydatidiform moles and malignant diseases that are referred as gestational trophoblastic neoplasia (GTN). Ultrasound plays a central role in the diagnosis of patients with hydatidiform mole. Other imaging modalities are useful in molar pregnancy, mainly for evaluating pulmonary complications and atypical presentation of hydatidiform mole. GTN typically arises after 20% of molar pregnancies but can uncommonly occur after nonmolar gestations. After uterine evacuation, serial human chorionic gonadotropin levels are evaluated in patients for early detection of GTN. Once GTN is suspected, Doppler ultrasound is the primary tool to confirm the diagnosis; however, magnetic resonance imaging can also help in selected cases. Metastatic disease workup can involve various modalities, including ultrasound, X-ray, computed tomography, magnetic resonance imaging and positron emission tomography/computed tomography. In this article, we review the main imaging modalities used to evaluate patients with GTD.eng
dc.language.isoeng
dc.publisherW B SAUNDERS CO-ELSEVIER INCeng
dc.relation.ispartofSeminars in Ultrasound Ct and Mri
dc.rightsrestrictedAccesseng
dc.subject.othercomplete hydatidiform moleeng
dc.subject.otheruterine arteriovenous-malformationseng
dc.subject.otherartery pulsatility indexeng
dc.subject.otherclinical presentationeng
dc.subject.othermethotrexate resistanceeng
dc.subject.otherultrasound diagnosiseng
dc.subject.othermanagementeng
dc.subject.otherneoplasiaeng
dc.subject.otherpregnancieseng
dc.subject.otherexperienceeng
dc.titleImaging in Gestational Trophoblastic Diseaseeng
dc.typearticleeng
dc.rights.holderCopyright W B SAUNDERS CO-ELSEVIER INCeng
dc.identifier.doi10.1053/j.sult.2019.03.002
dc.identifier.pmid31375173
dc.subject.wosRadiology, Nuclear Medicine & Medical Imagingeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
hcfmusp.description.beginpage332
hcfmusp.description.endpage349
hcfmusp.description.issue4
hcfmusp.description.volume40
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000479184000007
hcfmusp.origem.id2-s2.0-85063350388
hcfmusp.publisher.cityPHILADELPHIAeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceAgarwal R, 2012, BRIT J CANCER, V106, P1089, DOI 10.1038/bjc.2012.65eng
hcfmusp.relation.referenceAgarwal R, 2014, J REPROD MED, V59, P7eng
hcfmusp.relation.referenceBajaj SK, 2013, J OBSTET GYN INDIA, V64, P9eng
hcfmusp.relation.referenceBall L, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.07.20eng
hcfmusp.relation.referenceBerkowitz RS, 2009, NEW ENGL J MED, V360, P1639, DOI 10.1056/NEJMcp0900696eng
hcfmusp.relation.referenceBraga A, 2018, J REPROD MED, V63, P228eng
hcfmusp.relation.referenceBraga A, 2016, INT J GYNECOL CANCER, V26, P984, DOI 10.1097/IGC.0000000000000682eng
hcfmusp.relation.referenceBraga A, 2014, J REPROD MED, V59, P241eng
hcfmusp.relation.referenceAsmar FT, 2017, CLINICS, V72, P284, DOI 10.6061/clinics/2017(05)05eng
hcfmusp.relation.referenceCheung ANY, 2003, BEST PRACT RES CL OB, V17, P849, DOI 10.1016/S1521-6934(03)00094-4eng
hcfmusp.relation.referenceCortes-Charry R, 2012, J REPROD MED, V57, P329eng
hcfmusp.relation.referenceDarby S, 2009, GYNECOL ONCOL, V112, P155, DOI 10.1016/j.ygyno.2008.10.003eng
hcfmusp.relation.referenceDhanda S, 2014, RADIOL RES PRACT, V2014, P1eng
hcfmusp.relation.referenceDiver E, 2013, GYNECOL ONCOL, V130, P483, DOI 10.1016/j.ygyno.2013.06.014eng
hcfmusp.relation.referenceFINE C, 1989, OBSTET GYNECOL, V73, P414eng
hcfmusp.relation.referenceFisher RA, 2003, PLACENTA, V24, pS111, DOI 10.1053/plac.2002.0939eng
hcfmusp.relation.referenceFowler DJ, 2007, ULTRASOUND OBST GYN, V29, P76, DOI 10.1002/uog.3880eng
hcfmusp.relation.referenceFowler DJ, 2006, ULTRASOUND OBST GYN, V27, P56, DOI 10.1002/uog.2592eng
hcfmusp.relation.referenceHanna RK, 2010, ONCOLOGIST, V15, P593, DOI 10.1634/theoncologist.2010-0065eng
hcfmusp.relation.referenceHassadia A, 2012, J REPROD MED, V57, P297eng
hcfmusp.relation.referenceHorowitz NS, 2017, GYNECOL ONCOL, V144, P208, DOI 10.1016/j.ygyno.2016.10.024eng
hcfmusp.relation.referenceHSIEH FJ, 1994, CANCER-AM CANCER SOC, V74, P2361, DOI 10.1002/1097-0142(19941015)74:8<2361::AID-CNCR2820740822>3.0.CO;2-Geng
hcfmusp.relation.referenceHUBERMAN RP, 1982, AM J ROENTGENOL, V138, P71, DOI 10.2214/ajr.138.1.71eng
hcfmusp.relation.referenceImafuku Hitomi, 2018, Kobe J Med Sci, V64, pE1eng
hcfmusp.relation.referenceJauniaux E, 1998, ULTRASOUND OBST GYN, V11, P367, DOI 10.1046/j.1469-0705.1998.11050367.xeng
hcfmusp.relation.referenceJauniaux E, 2018, PLACENTA, V62, P28, DOI 10.1016/j.placenta.2017.12.008eng
hcfmusp.relation.referenceKohorn E I, 1987, Obstet Gynecol Surv, V42, P484, DOI 10.1097/00006254-198708000-00002eng
hcfmusp.relation.referenceLi J., 2016, SUSTAINABILITY, V8, P1eng
hcfmusp.relation.referenceLim AKP, 2002, RADIOLOGY, V222, P640, DOI 10.1148/radiol.2223010035eng
hcfmusp.relation.referenceLima Lana de Lourdes Aguiar, 2016, Radiol Bras, V49, P241, DOI 10.1590/0100-3984.2015.0073eng
hcfmusp.relation.referenceLin LH, 2018, J REPROD MED, V63, P271eng
hcfmusp.relation.referenceLin LH, 2017, GYNECOL ONCOL, V145, P88, DOI 10.1016/j.ygyno.2017.01.021eng
hcfmusp.relation.referenceLin LH, 2015, CLINICS, V70, P810, DOI 10.6061/clinics/2015(12)08eng
hcfmusp.relation.referenceLin LH, 2018, CASE REP OBSTET GYNE, V2018, P1eng
hcfmusp.relation.referenceLu D, 2017, INT J GYNECOL PATHOL, V36, P428, DOI 10.1097/PGP.0000000000000347eng
hcfmusp.relation.referenceLurain JR, 2011, AM J OBSTET GYNECOL, V204, P11, DOI 10.1016/j.ajog.2010.06.072eng
hcfmusp.relation.referenceLurain JR, 2010, AM J OBSTET GYNECOL, V203, P531, DOI 10.1016/j.ajog.2010.06.073eng
hcfmusp.relation.referenceMangili G, 2016, Q J NUCL MED MOL IM, V60, P103eng
hcfmusp.relation.referenceMcGrath S, 2010, BRIT J CANCER, V102, P810, DOI 10.1038/sj.bjc.6605529eng
hcfmusp.relation.referenceMUTO MG, 1991, J REPROD MED, V36, P57eng
hcfmusp.relation.referenceNgan HYS, 2018, INT J GYNECOL OBSTET, V143, P79, DOI 10.1002/ijgo.12615eng
hcfmusp.relation.referencePrice JM, 2015, INT J GYNECOL CANCER, V25, P1731, DOI 10.1097/IGC.0000000000000534eng
hcfmusp.relation.referenceROMERO R, 1985, OBSTET GYNECOL, V66, P553eng
hcfmusp.relation.referenceScholz NB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142545eng
hcfmusp.relation.referenceSebire NJ, 2002, LANCET, V359, P2165, DOI 10.1016/S0140-6736(02)09085-2eng
hcfmusp.relation.referenceSebire NJ, 2001, ULTRASOUND OBST GYN, V18, P662, DOI 10.1046/j.0960-7692.2001.00589.xeng
hcfmusp.relation.referenceSeckl MJ, 2013, ANN ONCOL, V24, P39, DOI 10.1093/annonc/mdt345eng
hcfmusp.relation.referenceSeckl MJ, 2010, LANCET, V376, P717, DOI 10.1016/S0140-6736(10)60280-2eng
hcfmusp.relation.referenceShaaban AM, 2017, RADIOGRAPHICS, V37, P681, DOI 10.1148/rg.2017160140eng
hcfmusp.relation.referenceSita-Lumsden A, 2013, BJOG-INT J OBSTET GY, V120, P1012, DOI 10.1111/1471-0528.12196eng
hcfmusp.relation.referenceSteigrad SJ, 2003, BEST PRACT RES CL OB, V17, P837, DOI 10.1016/S1521-6934(03)00049-Xeng
hcfmusp.relation.referenceSun SY, 2015, GYNECOL ONCOL, V138, P46, DOI 10.1016/j.ygyno.2015.05.002eng
hcfmusp.relation.referenceTidy JA, 2000, GYNECOL ONCOL, V78, P309, DOI 10.1006/gyno.2000.5839eng
hcfmusp.relation.referenceTouhami O, 2014, EUR J OBSTET GYN R B, V181, P54, DOI 10.1016/j.ejogrb.2014.07.023eng
hcfmusp.relation.referenceXiao C. W., 2015, BMC COMPLEM ALTERN M, V15, P1eng
hcfmusp.relation.referenceYamada Y, 2016, CASE REP OBSTET GYNE, V2016, P1eng
hcfmusp.relation.referenceZhou Q, 2005, J ULTRAS MED, V24, P15, DOI 10.7863/jum.2005.24.1.15eng
dc.description.indexMEDLINEeng
dc.identifier.eissn1558-5034
hcfmusp.citation.scopus3-
hcfmusp.scopus.lastupdate2022-06-10-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MOG
Departamento de Obstetrícia e Ginecologia - FM/MOG

Artigos e Materiais de Revistas Científicas - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/57
LIM/57 - Laboratório de Fisiologia Obstétrica

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_LIN_Imaging_in_Gestational_Trophoblastic_Disease_2019.PDF
  Restricted Access
publishedVersion (English)7.1 MBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.